AllSight
Companies · CAH · Wholesale-Drugs, Proprietaries & Druggists' Sundries · New debt · Aug 11, 2026

Cardinal replaces $4 billion of credit facilities with one longer-dated revolver

CARDINAL HEALTH INC (CAH) — what happened, in plain English, and what it means versus what the market expected.

This is a refinancing and simplification, not new funding. Cardinal replaced a $2.0 billion five-year revolver, a $1.0 billion 364-day revolver, and a $1.0 billion receivables-sale program with a single unsecured $4.0 billion revolving facility. Total stated capacity is therefore unchanged, while the new facility runs through August 7, 2031. (Credit Agreement; Terminated Facilities)

FacilityCapacityStatus / maturity
New unsecured revolving facility$4.0 billionThrough August 7, 2031 (Credit Agreement)
Former five-year revolver$2.0 billionTerminated August 7, 2026 (Terminated Facilities)
Former 364-day revolver$1.0 billionTerminated August 7, 2026 (Terminated Facilities)
Receivables sale program$1.0 billionTerminated August 7, 2026 (Terminated Facilities)

The main change is longer-dated, more centralized liquidity. The filing extends the key maturity to 2031, permits up to two additional years of extensions subject to conditions, and removes the separate receivables-financing structure. That improves financing visibility and administrative simplicity, but the filing does not disclose a draw, a new borrowing need, or an increase in aggregate committed capacity. (Credit Agreement)

The credit terms look ordinary rather than signaling a new problem. The facility includes customary covenants and a maximum consolidated net leverage ratio of 4.00-to-1.00. Because the filing provides no updated leverage, pricing, utilization, or operating forecast, it does not establish a meaningful earnings or balance-sheet surprise versus expectations. The appropriate read is routine and broadly neutral: better maturity coverage, but no incremental liquidity or strategic change is disclosed. (Credit Agreement)

Read the original 8-K on SEC EDGAR ↗
More from CARDINAL HEALTH INC (CAH)
Aug 11, 2026Underlying EPS beat and FY27 guide topped estimates despite a revenue missAug 5, 2026Appoints Baxter’s interim CFO as next chief accounting officerAll CAH filings, decoded →
Related companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact